Harvard
Markvardsen, LK, Carstens, A-KR
, Knak, KL, Overgaard, K
, Vissing, J & Andersen, H 2019, '
Muscle Strength and Aerobic Capacity in Patients with CIDP One Year after Participation in an Exercise Trial'
Journal of Neuromuscular Diseases, bind 6, nr. 1, s. 93-97.
https://doi.org/10.3233/JND-180344
APA
Markvardsen, L. K., Carstens, A-K. R.
, Knak, K. L., Overgaard, K.
, Vissing, J., & Andersen, H. (2019).
Muscle Strength and Aerobic Capacity in Patients with CIDP One Year after Participation in an Exercise Trial.
Journal of Neuromuscular Diseases,
6(1), 93-97.
https://doi.org/10.3233/JND-180344
CBE
MLA
Vancouver
Author
Bibtex
@article{704efb2d14714e28b6e513b5ea8a203f,
title = "Muscle Strength and Aerobic Capacity in Patients with CIDP One Year after Participation in an Exercise Trial",
abstract = "BACKGROUND: We have previously shown that patients with chronic inflammatory demyelinating polyneuropathy (CIDP) improve muscle strength and aerobic capacity after resistance and aerobic exercise.OBJECTIVE: The purpose of this study was to determine if muscle strength and aerobic capacity are preserved one year after discontinuation of regular exercise.METHODS: All patients in the previous exercise study were eligible for a one-year follow-up with measurement of combined isokinetic muscle strength (cIKS) by dynamometry and maximal oxygen consumption velocity (VO2-max).RESULTS: Ten of 17 patients accepted to participate in the follow-up study. Following the exercise study six patients discontinued exercise and at one-year follow-up cIKS had decreased by -13.0 {\%} (-25.8 to -2.9) (p = 0.03)) and VO2-max by -16.6 {\%} (-18.8 to -12.6) (p = 0.06). Four patients continued exercise (three with aerobic training and one with resistance training) and at one-year follow-up cIKS and VO2-max were preserved compared to the end of the exercise study (11.6 {\%} (-8.9 to 32.1) (p = 0.88) and -8.4 {\%} (-34.5 to -2.2) (p = 0.13), respectively).CONCLUSIONS: Continuation of aerobic and resistance exercise may preserve gains in muscle strength and aerobic capacity in patients with CIDP.",
keywords = "CIDP, aerobic training, immunoglobulin, muscle strength, resistance training, Muscle Strength Dynamometer, Follow-Up Studies, Humans, Middle Aged, Oxygen Consumption, Male, Treatment Outcome, Exercise Therapy, Exercise Tolerance, Female, Aged, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating/physiopathology, Muscle Strength",
author = "Markvardsen, {Lars K} and Carstens, {Anne-Kathrine R} and Knak, {Kirsten L} and Kristian Overgaard and John Vissing and Henning Andersen",
year = "2019",
doi = "10.3233/JND-180344",
language = "English",
volume = "6",
pages = "93--97",
journal = "Journal of Neuromuscular Diseases",
issn = "2214-3599",
publisher = "I O S Press",
number = "1",
}
RIS
TY - JOUR
T1 - Muscle Strength and Aerobic Capacity in Patients with CIDP One Year after Participation in an Exercise Trial
AU - Markvardsen, Lars K
AU - Carstens, Anne-Kathrine R
AU - Knak, Kirsten L
AU - Overgaard, Kristian
AU - Vissing, John
AU - Andersen, Henning
PY - 2019
Y1 - 2019
N2 - BACKGROUND: We have previously shown that patients with chronic inflammatory demyelinating polyneuropathy (CIDP) improve muscle strength and aerobic capacity after resistance and aerobic exercise.OBJECTIVE: The purpose of this study was to determine if muscle strength and aerobic capacity are preserved one year after discontinuation of regular exercise.METHODS: All patients in the previous exercise study were eligible for a one-year follow-up with measurement of combined isokinetic muscle strength (cIKS) by dynamometry and maximal oxygen consumption velocity (VO2-max).RESULTS: Ten of 17 patients accepted to participate in the follow-up study. Following the exercise study six patients discontinued exercise and at one-year follow-up cIKS had decreased by -13.0 % (-25.8 to -2.9) (p = 0.03)) and VO2-max by -16.6 % (-18.8 to -12.6) (p = 0.06). Four patients continued exercise (three with aerobic training and one with resistance training) and at one-year follow-up cIKS and VO2-max were preserved compared to the end of the exercise study (11.6 % (-8.9 to 32.1) (p = 0.88) and -8.4 % (-34.5 to -2.2) (p = 0.13), respectively).CONCLUSIONS: Continuation of aerobic and resistance exercise may preserve gains in muscle strength and aerobic capacity in patients with CIDP.
AB - BACKGROUND: We have previously shown that patients with chronic inflammatory demyelinating polyneuropathy (CIDP) improve muscle strength and aerobic capacity after resistance and aerobic exercise.OBJECTIVE: The purpose of this study was to determine if muscle strength and aerobic capacity are preserved one year after discontinuation of regular exercise.METHODS: All patients in the previous exercise study were eligible for a one-year follow-up with measurement of combined isokinetic muscle strength (cIKS) by dynamometry and maximal oxygen consumption velocity (VO2-max).RESULTS: Ten of 17 patients accepted to participate in the follow-up study. Following the exercise study six patients discontinued exercise and at one-year follow-up cIKS had decreased by -13.0 % (-25.8 to -2.9) (p = 0.03)) and VO2-max by -16.6 % (-18.8 to -12.6) (p = 0.06). Four patients continued exercise (three with aerobic training and one with resistance training) and at one-year follow-up cIKS and VO2-max were preserved compared to the end of the exercise study (11.6 % (-8.9 to 32.1) (p = 0.88) and -8.4 % (-34.5 to -2.2) (p = 0.13), respectively).CONCLUSIONS: Continuation of aerobic and resistance exercise may preserve gains in muscle strength and aerobic capacity in patients with CIDP.
KW - CIDP
KW - aerobic training
KW - immunoglobulin
KW - muscle strength
KW - resistance training
KW - Muscle Strength Dynamometer
KW - Follow-Up Studies
KW - Humans
KW - Middle Aged
KW - Oxygen Consumption
KW - Male
KW - Treatment Outcome
KW - Exercise Therapy
KW - Exercise Tolerance
KW - Female
KW - Aged
KW - Polyradiculoneuropathy, Chronic Inflammatory Demyelinating/physiopathology
KW - Muscle Strength
UR - http://www.scopus.com/inward/record.url?scp=85060995683&partnerID=8YFLogxK
U2 - 10.3233/JND-180344
DO - 10.3233/JND-180344
M3 - Journal article
VL - 6
SP - 93
EP - 97
JO - Journal of Neuromuscular Diseases
JF - Journal of Neuromuscular Diseases
SN - 2214-3599
IS - 1
ER -